 | Rigel Pharmaceuticals, Inc. | |||
| NMS : RIGL || Location: United States | ||||
$1.1-0.03 (-2.65%) |
2.97 M | 1.06 - 1.14 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 5.167 M |
| March 28, 2024 | 5.014 M |
| March 15, 2024 | 4.945 M |
| Feb. 29, 2024 | 3.738 M |
| Feb. 15, 2024 | 3.503 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.07 | -0.03 | 58.56% |
| 06/30/2023 | -0.08 | -0.04 | 49.75% |
| 03/31/2023 | -0.10 | -0.08 | 19.60% |
| 12/31/2022 | -0.11 | 0.01 | 108.74% |
| 09/30/2022 | -0.13 | -0.11 | 15.40% |
RIGL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 175.405M | Shares Float | 146.956M |
| Short Float | 5.167M | Market Cap | 192.95M |
| Institution ownership | 61.41% | Insider ownership | 2.106% |
| Earnings Date | 04/30/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.14 | Forward EPS | 0.09 |